The Molecular Pathogenesis and Experimental Therapy of IgA Nephropathy Recent Advances and Future Directions.

By  

Current Molecular Medicine, Vol. 1, Iss. 2, 2001-05 ,pp. : 183-196

Bentham Science Publishers

Access to resources Recommend Favorite

Pathogenic significance of IgA receptor interactions in IgA nephropathy

By Monteiro R.C.   Moura I.C.   Launay P.   Tsuge T.   Haddad E.   Benhamou M.   Cooper M.D.   Arcos-Fajardo M.  

Trends in Molecular Medicine, Vol. 8, Iss. 10, 2002-10 ,pp. : 464-468

Elsevier

Access to resources Recommend Favorite

Phenotypic Characterization of Cytokine Expression in Patients With IgA Nephropathy

By Yano Naohiro   Endoh Masayuki   Nomoto Yasuo   Sakai Hideto   Fadden Kimbery   Rifai Abdalla  

Journal of Clinical Immunology, Vol. 17, Iss. 5, 1997-09 ,pp. : 396-402

Springer Publishing Company

Access to resources Recommend Favorite

Outcome of renal transplants in patients with IgA nephropathy

By Koselj-Kajtna M.   Kandus A.   Koselj M.   Rott T.   Vizjak A.   Bren A.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3429-3430

Elsevier

Access to resources Recommend Favorite

Increased Apoptosis of CD20⁺ IgA⁺ B Cells is the Basis for IgA Deficiency: The Molecular Mechanism for Correction In Vitro by IL-10 and CD40L

By Husain Zaheed   Holodick Nichol   Day Caitlin   Szymanski Irma   Alper Chester  

Journal of Clinical Immunology, Vol. 26, Iss. 2, 2006-03 ,pp. : 113-125

Springer Publishing Company

Access to resources Recommend Favorite